Global and United States Monovalent Antivenom Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Monovalent Antivenom Product Introduction
• 1.2 Global Monovalent Antivenom Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Monovalent Antivenom Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global Monovalent Antivenom Sales in Volume for the Year 2017-2028
• 1.3 United States Monovalent Antivenom Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States Monovalent Antivenom Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States Monovalent Antivenom Sales in Volume for the Year 2017-2028
• 1.4 Monovalent Antivenom Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States Monovalent Antivenom in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of Monovalent Antivenom Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 Monovalent Antivenom Market Dynamics
  • 1.5.1 Monovalent Antivenom Industry Trends
  • 1.5.2 Monovalent Antivenom Market Drivers
  • 1.5.3 Monovalent Antivenom Market Challenges
  • 1.5.4 Monovalent Antivenom Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 Monovalent Antivenom Market Segment by Type
  • 2.1.1 Coral Snakes Antivenom
  • 2.1.2 Sea Snakes Antivenom
  • 2.1.3 Brown Snake Antivenom
  • 2.1.4 Others
• 2.2 Global Monovalent Antivenom Market Size by Type
  • 2.2.1 Global Monovalent Antivenom Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global Monovalent Antivenom Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global Monovalent Antivenom Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States Monovalent Antivenom Market Size by Type
  • 2.3.1 United States Monovalent Antivenom Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States Monovalent Antivenom Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States Monovalent Antivenom Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Monovalent Antivenom Market Segment by Application
  • 3.1.1 Non-profit Institutions
  • 3.1.2 Hospitals and Clinic
• 3.2 Global Monovalent Antivenom Market Size by Application
  • 3.2.1 Global Monovalent Antivenom Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global Monovalent Antivenom Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global Monovalent Antivenom Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States Monovalent Antivenom Market Size by Application
  • 3.3.1 United States Monovalent Antivenom Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States Monovalent Antivenom Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States Monovalent Antivenom Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Monovalent Antivenom Competitor Landscape by Company

• 4.1 Global Monovalent Antivenom Market Size by Company
  • 4.1.1 Top Global Monovalent Antivenom Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global Monovalent Antivenom Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global Monovalent Antivenom Sales by Manufacturer (2017-2022)
  • 4.1.4 Global Monovalent Antivenom Price by Manufacturer (2017-2022)
• 4.2 Global Monovalent Antivenom Concentration Ratio (CR)
  • 4.2.1 Monovalent Antivenom Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Monovalent Antivenom in 2021
  • 4.2.3 Global Monovalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Monovalent Antivenom Manufacturing Base Distribution, Product Type
  • 4.3.1 Global Monovalent Antivenom Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers Monovalent Antivenom Product Type
  • 4.3.3 Date of International Manufacturers Enter into Monovalent Antivenom Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States Monovalent Antivenom Market Size by Company
  • 4.5.1 Top Monovalent Antivenom Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Monovalent Antivenom Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States Monovalent Antivenom Sales by Players (2020, 2021 & 2022)

5 Global Monovalent Antivenom Market Size by Region

• 5.1 Global Monovalent Antivenom Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Monovalent Antivenom Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global Monovalent Antivenom Sales in Volume by Region: 2017-2022
  • 5.2.2 Global Monovalent Antivenom Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global Monovalent Antivenom Market Size in Value by Region (2017-2028)
  • 5.3.1 Global Monovalent Antivenom Sales in Value by Region: 2017-2022
  • 5.3.2 Global Monovalent Antivenom Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Monovalent Antivenom Market Size YoY Growth 2017-2028
  • 6.1.2 North America Monovalent Antivenom Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Monovalent Antivenom Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Monovalent Antivenom Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Monovalent Antivenom Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Monovalent Antivenom Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Monovalent Antivenom Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Monovalent Antivenom Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Monovalent Antivenom Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Monovalent Antivenom Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 CSL
  • 7.1.1 CSL Corporation Information
  • 7.1.2 CSL Description and Business Overview
  • 7.1.3 CSL Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 CSL Monovalent Antivenom Products Offered
  • 7.1.5 CSL Recent Development
• 7.2 Merck
  • 7.2.1 Merck Corporation Information
  • 7.2.2 Merck Description and Business Overview
  • 7.2.3 Merck Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 Merck Monovalent Antivenom Products Offered
  • 7.2.5 Merck Recent Development
• 7.3 BTG
  • 7.3.1 BTG Corporation Information
  • 7.3.2 BTG Description and Business Overview
  • 7.3.3 BTG Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 BTG Monovalent Antivenom Products Offered
  • 7.3.5 BTG Recent Development
• 7.4 Pfizer
  • 7.4.1 Pfizer Corporation Information
  • 7.4.2 Pfizer Description and Business Overview
  • 7.4.3 Pfizer Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 Pfizer Monovalent Antivenom Products Offered
  • 7.4.5 Pfizer Recent Development
• 7.5 Haffkine Bio-Pharmaceutical
  • 7.5.1 Haffkine Bio-Pharmaceutical Corporation Information
  • 7.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
  • 7.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Products Offered
  • 7.5.5 Haffkine Bio-Pharmaceutical Recent Development
• 7.6 Vins Bioproducts
  • 7.6.1 Vins Bioproducts Corporation Information
  • 7.6.2 Vins Bioproducts Description and Business Overview
  • 7.6.3 Vins Bioproducts Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.6.4 Vins Bioproducts Monovalent Antivenom Products Offered
  • 7.6.5 Vins Bioproducts Recent Development
• 7.7 Serum Biotech
  • 7.7.1 Serum Biotech Corporation Information
  • 7.7.2 Serum Biotech Description and Business Overview
  • 7.7.3 Serum Biotech Monovalent Antivenom Sales, Revenue and Gross Margin (2017-2022)
  • 7.7.4 Serum Biotech Monovalent Antivenom Products Offered
  • 7.7.5 Serum Biotech Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Monovalent Antivenom Industry Chain Analysis
• 8.2 Monovalent Antivenom Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Monovalent Antivenom Distributors
• 8.3 Monovalent Antivenom Production Mode & Process
• 8.4 Monovalent Antivenom Sales and Marketing
  • 8.4.1 Monovalent Antivenom Sales Channels
  • 8.4.2 Monovalent Antivenom Distributors
• 8.5 Monovalent Antivenom Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details